Categories

Volume 9 Issue 9 ( September, 2021 )

Original Articles

Assessment of outcome of different concentration of Hyoscine Butylbromide on course of labor
Dr. Nutan Verma, Dr. Deepika Verma

Background: Hyoscine butyl bromide (Buscopan) is being used as an agent for reducing the duration of labour. The present study was conducted to compare effect of different concentration of Hyoscine Butylbromide on course of labor. Materials & Methods: The present study was conducted 60 prim gravid women with term gestation. All were divided into 2 groups of 30 each. In group I 40 mg of intra-venous HBB in the early active phase of labor was given and in group II 60 mg of intra-venous HBB was given. Results: Each group had 60 patients each. Group I patients were given 40 mg of intra-venous HBB and group II received 60 mg of intra-venous HBB. The mode of delivery in group I was abdominal seen in 20 and 16 in group II. It was vaginal seen 40 in group I and 44 in group II. The difference was non- significant (P> 0.05). APGAR score at 1st minute in group I was 8.0 and in group II was 8.2, APGAR score at 5th minute in group I was 8.2 and in group II was 8.4. Estimated blood loss in group I was 324 ml and in group II was 356 ml, injection to delivery time in group I was 324 minutes and in group II was 3124 minutes, rupture of membranes to delivery was 106 minutes in group I and 124 minutes in group II. The difference was non- significant (P> 0.05). Conclusion: HBB is effective in significantly reducing the duration of the first stage of labor at both concentrations without any major adverse effects

 
Abstract View | Download PDF | Current Issue